More articles from From the Editor
- Trying to get ahead of Alzheimer disease
Sorting out patients destined to have Alzheimer disease remains a challenge.
- A seaworthy nautical tale and a pictured rash
In history’s first randomized controlled trial, James Lind gave 2 sailors lemons and oranges, and they got better.
- Cytokines and the still-baffling clinical biology of COVID-19
The primary culprit is not certain. Is it all immune damage, or is the continued persistence of coronavirus playing a role?
- Perioperative infection: Are we sure what to focus on?
Which immunosuppressive drugs pose the greater danger in the perioperative period: the newer biologics or corticosteroids?
- COVID-19 Curbside Consults at www.CCJM.org
These are tough times. This is a wicked disease. But healthcare providers are stepping up.
- The under- and overrecognized, and the elephant in the room
We internists must recognize the pine cones without losing our vision of the forest.
- An unending ode to pneumonia
The examination, history, and sometimes, sputum Gram stain and culture results still inform our clinical judgment.
- The search for precision
The day may come soon when we get EMR alerts if we try to prescribe certain drugs to patients with certain gene variants.
- Modifying genetic diseases: Promises to be realized?
Genetic engineering offers hope to patients and families who previously had little.
- Off-label and oft-prescribed
When prescribing drugs for uses beyond their FDA indications, we need to explain their anticipated side effects and benefits.